Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYS6090 in Combination Therapies for Advanced Colorectal Cancer
NCT07750041Phase 2Not yet recruiting
- Sponsor
- CSPC Megalith Biopharmaceutical Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in colorectal cancer (CRC), sponsored by CSPC Megalith Biopharmaceutical Co., Ltd.. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
toripalimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07750041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750041.